Transverse Myelitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Multiple Sclerosis (MS), confirmed using recognised medical guidelines (called McDonald criteria)
- Your MS can be of any type, including a single attack, relapsing-remitting, secondary progressive, or primary progressive MS
- You have a condition called Radiologically Isolated Syndrome (RIS), meaning MS-like changes were found on a brain scan but you have no symptoms (this will be reviewed by a specialist group)
- You have had a Clinically Isolated Syndrome (CIS), meaning a first episode of symptoms that may suggest MS
- You have Neuromyelitis Optica (NMO) or a related condition (this will be reviewed by a specialist group)
- You are currently pregnant — you can join at any point during your pregnancy, though joining as early as possible after finding out you are pregnant is encouraged
- There is no age limit — children under 18 may also be included, as long as their parents give consent on their behalf
- You are able to give your informed agreement to take part in the study
- You are able to read and/or understand French
Who may not be able to join:
- There are no specific exclusion criteria listed for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sandra VUKUSIC, Prof., Hospices Civils de Lyon
Phone: 4 72 68 13 13
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 during pregnancy period; Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 during post-partum period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.